Bringing Health Care’s Vision of Tomorrow Into Focus | UMIACS

Published on : Published by : BioBuzz Media

With $5 million from the U.S. National Science Foundation (NSF) and technology titans including Google, Microsoft and Meta (formerly known as Facebook), a trio of academic institutions are collaborating with industry and the federal government to develop, test and certify XR technologies in medicine and health care.These medical examples of extended reality (XR)—the umbrella term used for technology based in virtual and augmented reality or other immersive media—are already being prototyped or tested in clinical trials. But its widespread use in hospitals and other health care settings is currently hampered by technical challenges and sparse regulatory guidelines.
Now, with $5 million from the U.S. National Science Foundation (NSF) and technology titans including Google, Microsoft and Meta (formerly known as Facebook), a trio of academic institutions are collaborating with industry and the federal government to develop, test and certify XR technologies in medicine and health care.
The new Center for Medical Innovations in Extended Reality, known as MIXR, joins University of Maryland computer scientists and engineers with physicians and clinicians at the University of Maryland School of Medicine in Baltimore and the University of Michigan to improve medical training, patient management and health care outcomes across all areas of…

Governor Hogan Announces Maryland Cancer Moonshot Initiative; $216 Million in Initial Investments in Comprehensive Cancer Centers, Cutting-Edge Research of Treatments and Cures

Published on : Published by : BioBuzz Media

Governor Larry Hogan today announced a new Maryland Cancer Moonshot Initiative to expand and accelerate cancer detection, screening, prevention, treatment, and research in the state. The state is committing $216 million in investments as a down payment to jumpstart this far-reaching initiative to save lives, including the first ever comprehensive cancer center in Prince George’s County.

Institute for Bioscience and Biotechnology Research Receives $16.8 M Investment from the National Institute of Standards and Technology

IBBR Logo
Published on : Published by : BioBuzz Media

The Institute for Bioscience and Biotechnology Research (IBBR) announces a newly funded five-year cooperative agreement with the National Institute of Standards and Technology (NIST) headed by the Co-Directors of IBBR, Dr. David J. Weber (PI) and Dr. John Marino (NIST). This award provides more than $3.3 million each year to support groundbreaking research, including technology and standards development that will impact vaccine and therapeutic discovery and development, and to improve access to life-saving treatments for addressing other crucial health challenges.

This University Startup Found Strong Support and Space Without Leaving Town

Published on : Published by : BioBuzz Media

Biomedical innovations can take a decade or more of ongoing research and development before they are ready to be used to treat patients. Even with funding and expert scientists, the most promising technologies can fail to go to market if entrepreneurs don’t have the experience or support to navigate the long and tedious drug development process.
A local resource is helping university-founded startups find success.
From a small lab space within the University of Maryland School of Medicine, Distinguished University Professor Vincent C.O. Njar, Ph.D., made an incredible discovery. Through his research, he developed novel small molecules with the potential to inhibit the growth of and treat breast cancer, with possible applications in dermatology and other types of cancer. Dr. Njar’s discovery could offer better outcomes for a range of patients.
To help clear the path to market, University of Maryland, Baltimore’s (UMB) New Ventures team worked with Dr. Njar to establish his startup, Isoprene Pharmaceuticals, Inc. The New Ventures program, run by a team with

5 Questions With Julie Lenzer, Chief Innovation Officer, University of Maryland

Published on : Published by : BioBuzz Media

A serial entrepreneur and ecosystem builder, Julie Lenzer is currently the Chief Innovation Officer at the University of Maryland and Founding Director for the newly-launched Quantum Startup Foundry. In these roles, she is charged with fostering and deploying innovation to drive economic and social impact from both university-affiliated and community-based innovators and oversees the university’s tech transfer office, the Maryland Small Business Development Center (SBDC), the Veteran’s Business Outreach Center (VBOC), the Mixed/Augmented/Virtual Reality Innovation Center (MAVRIC), as well as university engagement with the Discovery District (UMD’s 150-acre research park). An active angel investor, she is also on the investment committee of the $10M Maryland Momentum Fund and UMD’s newly-launched Discovery Fund.

Maryland Commerce Supports Research Professorships at Eight Higher Education Institutions

Published on : Published by : BioBuzz Media

The Maryland Department of Commerce joined eight local colleges and universities in endowing a total of $21.2 million to fund a dozen new research professorships. The endowments were made through the Maryland E-Nnovation Initiative (MEI), a state program created to spur basic and applied research in scientific and technical fields at the colleges and universities. The schools raised a total of more than $10.6 million in private funding for each chair and Maryland Commerce approved matching grants of $10.6 million to support the endowments.

5 Questions with Leah Sera, PharmD, MA, BCPS, Program Director, MS in Medical Cannabis Science and Therapeutics (MCST), Associate Professor, University of Maryland School of Pharmacy

Published on : Published by : Andy Eckert

Leah Sera, PharmD, MA, BCPS, is the Program Director, MS in Medical Cannabis Science and Therapeutics (MCST), and an Associate Professor, University of Maryland School of Pharmacy. She is currently an associate professor in the Department of Pharmacy Practice and Science. Her clinical specialties are pain management and palliative care.

5 Questions with Nivedita Hegdekar, Scientific Writer, and Communications Co-Chair for the Women in Bio Capital Region Chapter

Published on : Published by : Andy Eckert

Nivedita ‘Niv’ Hegdekar is a graduate student at the University of Maryland, Baltimore pursuing a dual degree in biomedical sciences and patent law. Prior to joining her PhD program, she obtained her degree in pharmacy and pharmaceutical sciences from the prestigious Institute of Chemical Technology, Mumbai, India.

5 Questions with Natalie McKinney, Industry Programs Director, Biologics, US Pharmacopeia

Published on : Published by : Andy Eckert

Natalie McKinney is a marketing strategy leader with 15+ years of experience in life sciences and technology organizations. She uses data-driven, customer-centric approaches to gain a deep understanding of dynamic customer needs and drivers. She enjoys leveraging internal and external relationships to build a holistic customer view and gains alignment on high-impact, right-sized product and marketing investments that are timed appropriately for the market.

‘Best Kept Secret’ MDC Provides Path for Medical Device Innovations

Published on : Published by : Alex Keown

In the heart of pharmaceutical and medical innovation lies an undiscovered treasure that provides a pathway for med-tech innovation, the Maryland Development Council (MDC). The council is a MedTech Startup Studio that works with inventors to develop their ideas into working prototypes and marketable products.